메뉴 건너뛰기




Volumn 129, Issue 6, 2012, Pages 704-709

Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis

Author keywords

Cardiovascular disease; Carotid atherosclerosis; Continuous ambulatory peritoneal dialysis (CAPD); Homocysteine; Kynurenic acid

Indexed keywords

HOMOCYSTEIC ACID; KYNURENIC ACID;

EID: 84861338062     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.08.016     Document Type: Article
Times cited : (17)

References (24)
  • 1
    • 10044285942 scopus 로고    scopus 로고
    • Cardiovascular risk in peritoneal dialysis
    • S. Prichard Cardiovascular risk in peritoneal dialysis Contrib Nephrol 140 2003 82 90
    • (2003) Contrib Nephrol , vol.140 , pp. 82-90
    • Prichard, S.1
  • 2
    • 0028046085 scopus 로고
    • Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis
    • N. Lameire, P. Bernaert, M.-C. Lambert, and D. Vijt Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis Kidney Int 46 Suppl. 48 1994 S31 S38
    • (1994) Kidney Int , vol.46 , Issue.SUPPL. 48
    • Lameire, N.1    Bernaert, P.2    Lambert, M.-C.3    Vijt, D.4
  • 3
    • 4243159858 scopus 로고    scopus 로고
    • Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease
    • G. Buccianti, I. Baragetti, F. Barmonti, S. Furiani, V. Dorighet, and C. Patrosso Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease J Nephrol 17 2004 405 410
    • (2004) J Nephrol , vol.17 , pp. 405-410
    • Buccianti, G.1    Baragetti, I.2    Barmonti, F.3    Furiani, S.4    Dorighet, V.5    Patrosso, C.6
  • 5
    • 68849101346 scopus 로고    scopus 로고
    • Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: A meta-analysis
    • J. Heinz, S. Kropf, C. Luley, and J. Dierkes Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis Am J Kidney Dis 54 2009 478 489
    • (2009) Am J Kidney Dis , vol.54 , pp. 478-489
    • Heinz, J.1    Kropf, S.2    Luley, C.3    Dierkes, J.4
  • 6
    • 0033620779 scopus 로고    scopus 로고
    • Homocysteine and vascular disease
    • G.J. Hankey, and J.W. Eikelboom Homocysteine and vascular disease Lancet 354 1999 407 413
    • (1999) Lancet , vol.354 , pp. 407-413
    • Hankey, G.J.1    Eikelboom, J.W.2
  • 7
  • 8
    • 77950916697 scopus 로고    scopus 로고
    • The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients
    • S. Ertek, A.N. Torun, and K. Ates The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients Int Urol Nephrol 42 2010 211 218
    • (2010) Int Urol Nephrol , vol.42 , pp. 211-218
    • Ertek, S.1    Torun, A.N.2    Ates, K.3
  • 10
    • 16244382834 scopus 로고    scopus 로고
    • Circulating soluble vascular cell adhesion molecule 1: Relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients
    • A.Y. Wang, C.W. Lam, M. Wang, J. Woo, I.H. Chan, S.F. Lui, J.E. Sanderson, and P.K. Li Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients Am J Kidney Dis 45 2005 715 729
    • (2005) Am J Kidney Dis , vol.45 , pp. 715-729
    • Wang, A.Y.1    Lam, C.W.2    Wang, M.3    Woo, J.4    Chan, I.H.5    Lui, S.F.6    Sanderson, J.E.7    Li, P.K.8
  • 11
    • 33747819235 scopus 로고    scopus 로고
    • Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease
    • K. Schroecksnadel, B. Frick, C. Winkler, and D. Fusch Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease Curr Vasc Pharmacol 4 2006 205 213
    • (2006) Curr Vasc Pharmacol , vol.4 , pp. 205-213
    • Schroecksnadel, K.1    Frick, B.2    Winkler, C.3    Fusch, D.4
  • 12
    • 0027486072 scopus 로고
    • Neuropharmacology of quinolinic and kynurenic acids
    • T.W. Stone Neuropharmacology of quinolinic and kynurenic acids Pharmacol Rev 45 1993 309 379
    • (1993) Pharmacol Rev , vol.45 , pp. 309-379
    • Stone, T.W.1
  • 13
    • 67349241663 scopus 로고    scopus 로고
    • The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease
    • K. Pawlak, T. Domaniewski, M. Mysliwiec, and D. Pawlak The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease Atherosclerosis 204 2009 309 314
    • (2009) Atherosclerosis , vol.204 , pp. 309-314
    • Pawlak, K.1    Domaniewski, T.2    Mysliwiec, M.3    Pawlak, D.4
  • 14
    • 67349118403 scopus 로고    scopus 로고
    • Kynurenine, quinolinic acid - The new factors linked to carotid atherosclerosis in patients with end-stage renal disease
    • K. Pawlak, S. Brzosko, M. Mysliwiec, and D. Pawlak Kynurenine, quinolinic acid - The new factors linked to carotid atherosclerosis in patients with end-stage renal disease Atherosclerosis 204 2009 561 566
    • (2009) Atherosclerosis , vol.204 , pp. 561-566
    • Pawlak, K.1    Brzosko, S.2    Mysliwiec, M.3    Pawlak, D.4
  • 15
    • 76449091049 scopus 로고    scopus 로고
    • Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients
    • K. Pawlak, M. Mysliwiec, and D. Pawlak Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients Thromb Res 125 2010 e40 e45
    • (2010) Thromb Res , vol.125
    • Pawlak, K.1    Mysliwiec, M.2    Pawlak, D.3
  • 17
    • 22144446744 scopus 로고    scopus 로고
    • Homocysteine, a risk factor for atherosclerosis, biophasically changes the endothelial production of kynurenic acid
    • J. Stazka, P. Luchowski, and E.M. Urbanska Homocysteine, a risk factor for atherosclerosis, biophasically changes the endothelial production of kynurenic acid Eur J Pharmacol 517 2005 217 223
    • (2005) Eur J Pharmacol , vol.517 , pp. 217-223
    • Stazka, J.1    Luchowski, P.2    Urbanska, E.M.3
  • 18
    • 70549088032 scopus 로고    scopus 로고
    • Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells
    • K. Wejksza, W. Rzeski, and W.A. Turski Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells Pharmacol Rep 61 2009 751 756
    • (2009) Pharmacol Rep , vol.61 , pp. 751-756
    • Wejksza, K.1    Rzeski, W.2    Turski, W.A.3
  • 20
    • 0036184490 scopus 로고    scopus 로고
    • Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure
    • D. Pawlak, A. Tankiewicz, P. Mysliwiec, and W. Buczko Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure Nephron 90 2002 328 335
    • (2002) Nephron , vol.90 , pp. 328-335
    • Pawlak, D.1    Tankiewicz, A.2    Mysliwiec, P.3    Buczko, W.4
  • 23
    • 0035478066 scopus 로고    scopus 로고
    • The brain metabolite kynurenic acid metabolite inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: Physiopathological implications
    • C. Hilmas, E.F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E.X. Albuquerque The brain metabolite kynurenic acid metabolite inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: physiopathological implications J Neurosci 21 2001 7463 7473
    • (2001) J Neurosci , vol.21 , pp. 7463-7473
    • Hilmas, C.1    Pereira, E.F.2    Alkondon, M.3    Rassoulpour, A.4    Schwarcz, R.5    Albuquerque, E.X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.